Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer

Enadenotucirev (EnAd) is a group B oncolytic adenovirus developed for systemic delivery and currently undergoing clinical evaluation for advanced cancer therapy. For differentiated carcinomas, systemic delivery would likely expose virus particles to the basolateral surface of cancer cells rather tha...

Full description

Saved in:
Bibliographic Details
Main Authors: Chia, Suet Lin, Lei, Janet, Ferguson, David J. P., Dyer, Arthur, Fishera, Kerry D., Seymour, Leonard W.
Format: Article
Language:en
Published: Elsevier 2017
Online Access:http://psasir.upm.edu.my/id/eprint/61987/1/Group%20B%20adenovirus%20enadenotucirev%20infects%20polarised%20colorectal%20cancer%20cells%20.pdf
http://psasir.upm.edu.my/id/eprint/61987/
https://www.sciencedirect.com/science/article/pii/S0042682217300521?via%3Dihub
Tags: Add Tag
No Tags, Be the first to tag this record!